Insider · CIK 0001013603

WERNER HAROLD R

Reports to the SEC for 15 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001013603

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-07-30	CYPHCYPHERPUNK TECHNOLOGIES INC. · Warrant (Right to Buy)J Other	10% Owner	JOther	+2,137 sh	—	—	2,137
2013-12-06	XNCRXencor Inc · Series A-1 Preferred StockC Conversion	Director	CConversion	−3.21M sh	—	—	0
2013-12-06	XNCRXencor IncC Conversion	Director	CConversion	+1.04M sh	—	—	1,035,407
2009-06-23	MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2008-06-04	MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2007-06-13	GENVEC INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2006-06-23	GENVEC INCS Sale	Director	SSale	−6.85M sh	$1.25	−$8.57M	3,582,000
2005-05-25	MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2005-04-29	MiddleBrook Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.76M sh	$3.98	+$7M	10,963,327
2005-04-29	MiddleBrook Pharmaceuticals, Inc.WarrantP Purchase	Director, 10% Owner	PPurchase	+616K sh	$3.98	+$2.45M	615,578
2003-10-22	MiddleBrook Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+904K sh	—	—	1,898,006
2003-10-22	MiddleBrook Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+952K sh	—	—	993,834
2003-10-22	MiddleBrook Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.78M sh	—	—	3,676,609
2003-10-22	MiddleBrook Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+3.47M sh	—	—	7,150,968
2003-10-22	MiddleBrook Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+2.05M sh	—	—	9,204,532
2003-10-22	MiddleBrook Pharmaceuticals, Inc.Series A Convertible PreferredC Conversion	Director, 10% Owner	CConversion	−1.74M sh	—	—	0
2003-10-22	MiddleBrook Pharmaceuticals, Inc.Series B Convertible PreferredC Conversion	Director, 10% Owner	CConversion	−1.65M sh	—	—	0
2003-10-22	MiddleBrook Pharmaceuticals, Inc.Series C Convertible PreferredC Conversion	Director, 10% Owner	CConversion	−3.25M sh	—	—	0
2003-10-22	MiddleBrook Pharmaceuticals, Inc.Series D Convertible PreferredC Conversion	Director, 10% Owner	CConversion	−6.36M sh	—	—	0
2003-10-22	MiddleBrook Pharmaceuticals, Inc.Series E Convertible PreferredC Conversion	Director, 10% Owner	CConversion	−3.76M sh	—	—	0
2003-10-16	MiddleBrook Pharmaceuticals, Inc.Option (Right to Buy)A Award	Director, 10% Owner	AAward	+27.3K sh	—	—	27,321

Recent filings

Accepted (ET)
Aug 14
WERNER HAROLD R0001104659-18-048857
SEC(opens sec.gov)
Dec 64
Xencor Inc0001209191-13-055668
SEC(opens sec.gov)
Jun 244
WERNER HAROLD R0001209191-09-033611
SEC(opens sec.gov)
Jun 194
MiddleBrook Pharmaceuticals, Inc.0001231919-08-000080
SEC(opens sec.gov)
Jun 154
GENVEC INC0001231919-07-000047
SEC(opens sec.gov)
Jun 264
WERNER HAROLD R0001231919-06-000101
SEC(opens sec.gov)
May 274
ADVANCIS PHARMACEUTICAL CORP0001231919-05-000041
SEC(opens sec.gov)
May 24
ADVANCIS PHARMACEUTICAL CORP0001231919-05-000031
SEC(opens sec.gov)
Oct 234
ADVANCIS PHARMACEUTICAL CORP0001231919-03-000158
SEC(opens sec.gov)

Companies

Address

C/O HEALTHCARE VENTURES LLC 44 NASSAU STREET

PRINCETON, NJ, 08542